These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11741668)

  • 1. Effects of yellow fever vaccination.
    Troillet N; Laurencet F
    Lancet; 2001 Dec; 358(9296):1908-9. PubMed ID: 11741668
    [No Abstract]   [Full Text] [Related]  

  • 2. History of thymoma and yellow fever vaccination.
    Barwick Eidex R;
    Lancet; 2004 Sep 11-17; 364(9438):936. PubMed ID: 15364184
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of yellow fever vaccination.
    Adhiyaman V; Oke A; Cefai C; Adhiyaman V; Oke A; Cefai C
    Lancet; 2001 Dec; 358(9296):1907-8. PubMed ID: 11741667
    [No Abstract]   [Full Text] [Related]  

  • 4. Suspected YF-AND after yellow fever vaccination in Finland.
    Jääskeläinen AJ; Huhtamo E; Kivioja R; Domingo C; Vene S; Kallio-Kokko H; Niedrig M; Tienari PJ; Vapalahti O
    J Clin Virol; 2014 Nov; 61(3):444-7. PubMed ID: 25223921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.
    Engel AR; Vasconcelos PF; McArthur MA; Barrett AD
    Vaccine; 2006 Apr; 24(15):2803-9. PubMed ID: 16464518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yellow fever vaccination and neurological complications.
    Bayão TS; Cupertino MDC; Gomes AP; Siqueira-Batista R
    Rev Soc Bras Med Trop; 2018; 51(5):723-724. PubMed ID: 30304289
    [No Abstract]   [Full Text] [Related]  

  • 7. Yellow fever vaccine-associated viscerotropic disease and death in Spain.
    Doblas A; Domingo C; Bae HG; Bohórquez CL; de Ory F; Niedrig M; Mora D; Carrasco FJ; Tenorio A
    J Clin Virol; 2006 Jun; 36(2):156-8. PubMed ID: 16597510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
    Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
    Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow fever: epidemiology and prevention.
    Barnett ED
    Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.
    Wkly Epidemiol Rec; 2013 Jul; 88(27):269-83. PubMed ID: 23909008
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular disease and yellow fever.
    Gualandro DM; Bellei N; Oliveira MT; Montenegro S
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):1-2. PubMed ID: 29561932
    [No Abstract]   [Full Text] [Related]  

  • 12. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza-like illness after yellow fever vaccination.
    Pellegrino P; Carnovale C; Radice S; Clementi E
    J Clin Virol; 2014 Jun; 60(2):181. PubMed ID: 24768323
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of yellow fever vaccine-associated disease.
    Isenman H; Burns A
    N Z Med J; 2012 Feb; 125(1349):92-5. PubMed ID: 22327162
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe Yellow fever vaccine-associated disease: a case report and current overview].
    Slesak G; Gabriel M; Domingo C; Schäfer J
    Dtsch Med Wochenschr; 2017 Aug; 142(16):1219-1222. PubMed ID: 28810279
    [No Abstract]   [Full Text] [Related]  

  • 16. What Controls the Acute Viral Infection Following Yellow Fever Vaccination?
    Moore J; Ahmed H; Jia J; Akondy R; Ahmed R; Antia R
    Bull Math Biol; 2018 Jan; 80(1):46-63. PubMed ID: 29110131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inactivated cell-culture vaccine against yellow fever.
    Monath TP; Fowler E; Johnson CT; Balser J; Morin MJ; Sisti M; Trent DW
    N Engl J Med; 2011 Apr; 364(14):1326-33. PubMed ID: 21470010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Yellow fever].
    Wiercińska-Drapało A
    Przegl Epidemiol; 2004; 58 Suppl 1():101-5. PubMed ID: 15807166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow fever-associated viscerotropic disease in Barcelona, Spain.
    Muñoz J; Vilella A; Domingo C; Nicolas JM; de Ory F; Corachan M; Tenorio A; Gascon J
    J Travel Med; 2008; 15(3):202-5. PubMed ID: 18494699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of yellow fever 17D genome in urine.
    Domingo C; Yactayo S; Agbenu E; Demanou M; Schulz AR; Daskalow K; Niedrig M
    J Clin Microbiol; 2011 Feb; 49(2):760-2. PubMed ID: 21106799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.